Company intelligence / Profile preview

ASUS Pharma

Taipei, Taiwan

Ownership: Private
Development stage: Other

Overview

ASUS Pharma is a biotechnology company focused on the development of innovative therapeutic solutions for oncology and immunology. The company leverages advanced drug discovery platforms to identify and optimize novel small molecules and biologics targeting key pathways in cancer progression. ASUS Pharma's pipeline includes several candidates in various stages of clinical and preclinical development, with a primary focus on addressing unmet medical needs in solid tumors. By integrating cutting-edge research with strategic partnerships, the company aims to deliver high-impact treatments that improve patient outcomes globally.

Therapeutic areas: Oncology
Modalities: Small moleculeMonoclonal antibody
Industry: Biotech

Beyond the preview

Go deeper on ASUS Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ASUS Pharma.

Explore the full profile